Comments
Loading...
Vincerx Pharma (VINC) Forecast
NewsEarningsVincerx Pharma (VINC) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestVincerx Pharma (NASDAQ:VINC) Stock Quotes, Forecast and News Summary
Vincerx Pharma Stock (NASDAQ: VINC) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Vincerx Pharma (VINC) stock?
You can purchase shares of Vincerx Pharma (NASDAQ:VINC) through any online brokerage.
Who are Vincerx Pharma (VINC) competitors?
Other companies in Vincerx Pharma’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), T2 Biosystems (NASDAQ:TTOO) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for Vincerx Pharma (VINC) stock?
Vincerx Pharma has a consensus price target of $8.80.
What is the current price for Vincerx Pharma (VINC)?
The stock price for Vincerx Pharma (NASDAQ: VINC) is $0.1904 last updated December 26, 2024 at 12:22 PM EST.
Does Vincerx Pharma (VINC) pay a dividend?
There are no upcoming dividends for Vincerx Pharma.
When is Vincerx Pharma (NASDAQ:VINC) reporting earnings?
Vincerx Pharma’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Vincerx Pharma (VINC) going to split?
There is no upcoming split for Vincerx Pharma.
What sector and industry does Vincerx Pharma (VINC) operate in?
Vincerx Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.